Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture Review
| Author: | Abramson, D. H. |
| Review Title: | Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture |
| Abstract: | Retinoblatoma is now the pediatric cancer with the highest cure rate. More than any other ocular malignancy the approach to this cancer has changed dramatically in the past 10 years. Most of the things taught to the majority of all Ophthalmology residents is out of date. Because few Ophthalmologists deal with retinoblastoma they are not aware of these seismic changes so this summary of my Curtin lectures outlines some of the major changes all Ophthalmologists should be familiar with. |
| Keywords: | chemotherapy; radiation; melphalan; retinoblastoma; risk; survivors; tumors; delivery; intraarterial chemotherapy; rb1; pgd; cancer; intravitreal chemotherapy; choroidal invasion |
| Journal Title: | Ophthalmic Genetics |
| Volume: | 44 |
| Issue: | 4 |
| ISSN: | 1381-6810 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2023-01-01 |
| Start Page: | 321 |
| End Page: | 326 |
| Language: | English |
| ACCESSION: | WOS:000961479200001 |
| DOI: | 10.1080/13816810.2023.2189948 |
| PROVIDER: | wos |
| PUBMED: | 36995014 |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is David H. Abramson -- Source: Wos |
